Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin for Prevention of Cardiac Surgery-associated AKI
NCT03007537Terminated
- Sponsor
- Nanjing First Hospital
- Start
- Oct 2015
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of erythropoietin in acute kidney injury (AKI) (2 arms), sponsored by Nanjing First Hospital. Primary endpoint: Acute Kidney Injury at 7 days. Started Oct 2015; status: terminated.
02
Drugs
erythropoietin
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT03007537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03007537.